$IDAI
T Stamp Inc

2022 Q1 Form 10-Q Financial Statement

#000141057822001381 Filed on May 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q1
Revenue $2.821M $2.096M $532.3K
YoY Change 429.99% 69.04%
Cost Of Revenue $694.0K $297.7K $260.0K
YoY Change 166.92% -71.65%
Gross Profit $2.127M $1.798M $270.0K
YoY Change 687.8% 899.12%
Gross Profit Margin 75.4% 85.8% 50.72%
Selling, General & Admin $3.121M $2.212M $1.334M
YoY Change 133.92% -26.28%
% of Gross Profit 146.71% 122.98% 494.09%
Research & Development $493.7K $1.403M $755.0K
YoY Change -34.61% -28.07%
% of Gross Profit 23.21% 77.99% 279.64%
Depreciation & Amortization $153.9K $151.0K $121.5K
YoY Change 26.74% 25.86%
% of Gross Profit 7.24% 8.4% 44.98%
Operating Expenses $4.462M $3.765M $2.468M
YoY Change 80.8% -25.73%
Operating Profit -$1.641M -$1.967M -$1.936M
YoY Change -15.22% -59.78%
Interest Expense $36.63K -$28.69K -$30.00K
YoY Change -222.1% -4.37%
% of Operating Profit
Other Income/Expense, Net -$50.94K -$28.25K -$96.23K
YoY Change -47.06% -112.84%
Pretax Income -$1.692M -$2.024M -$2.032M
YoY Change -16.72% -64.18%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.692M -$2.023M -$2.032M
YoY Change -16.72% -64.19%
Net Earnings / Revenue -59.98% -96.53% -381.73%
Basic Earnings Per Share -$0.07 -$0.11
Diluted Earnings Per Share -$0.07 -$86.91K -$0.11
COMMON SHARES
Basic Shares Outstanding 22.75M 17.81M
Diluted Shares Outstanding 22.75M 17.81M

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.836M $3.476M
YoY Change 136.44%
Cash & Equivalents $5.836M $3.476M $2.097M
Short-Term Investments
Other Short-Term Assets $1.061M $927.8K
YoY Change 101.7%
Inventory
Prepaid Expenses $483.3K $320.0K
Receivables $1.033M $1.278M
Other Receivables $161.2K $82.44K
Total Short-Term Assets $8.091M $5.764M
YoY Change 176.55%
LONG-TERM ASSETS
Property, Plant & Equipment $111.6K $111.8K
YoY Change -12.66%
Goodwill $1.249M $1.249M
YoY Change 0.0%
Intangibles $204.6K $201.8K
YoY Change 801.65%
Long-Term Investments
YoY Change
Other Assets $150.6K $178.1K
YoY Change -10.01%
Total Long-Term Assets $2.962M $2.900M
YoY Change 6.3%
TOTAL ASSETS
Total Short-Term Assets $8.091M $5.764M
Total Long-Term Assets $2.962M $2.900M
Total Assets $11.05M $8.665M
YoY Change 80.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $653.8K $304.1K
YoY Change -20.07%
Accrued Expenses $1.318M $1.060M
YoY Change 30.94%
Deferred Revenue $321.5K $503.4K
YoY Change 7.32%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $2.465M $2.400M
YoY Change -2.1%
LONG-TERM LIABILITIES
Long-Term Debt $838.1K $856.3K
YoY Change
Other Long-Term Liabilities $334.1K $374.7K
YoY Change 29.2%
Total Long-Term Liabilities $838.1K $856.3K
YoY Change 195.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.465M $2.400M
Total Long-Term Liabilities $838.1K $856.3K
Total Liabilities $3.637M $3.631M
YoY Change 32.56%
SHAREHOLDERS EQUITY
Retained Earnings -$28.90M -$27.21M
YoY Change 49.9%
Common Stock $232.5K $204.8K
YoY Change 15.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares $282.6K $282.6K
Shareholders Equity $7.255M $4.872M
YoY Change
Total Liabilities & Shareholders Equity $11.05M $8.665M
YoY Change 80.03%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q1
OPERATING ACTIVITIES
Net Income -$1.692M -$2.023M -$2.032M
YoY Change -16.72% -64.19%
Depreciation, Depletion And Amortization $153.9K $151.0K $121.5K
YoY Change 26.74% 25.86%
Cash From Operating Activities -$1.140M -$1.444M -$2.132M
YoY Change -46.54% 42.97%
INVESTING ACTIVITIES
Capital Expenditures $10.06K -$136.4K $497.00
YoY Change 1923.94% -164.96%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$90.00K
YoY Change -100.0%
Cash From Investing Activities -$244.8K -$136.4K -$233.9K
YoY Change 4.63% -35.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $203.4K $2.406M
YoY Change -91.55%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.696M 4.820M 2.947M
YoY Change 25.42% 9540.4%
NET CHANGE
Cash From Operating Activities -1.140M -1.444M -2.132M
Cash From Investing Activities -244.8K -136.4K -233.9K
Cash From Financing Activities 3.696M 4.820M 2.947M
Net Change In Cash 2.360M 3.240M 627.2K
YoY Change 276.35% -376.91%
FREE CASH FLOW
Cash From Operating Activities -$1.140M -$1.444M -$2.132M
Capital Expenditures $10.06K -$136.4K $497.00
Free Cash Flow -$1.150M -$1.308M -$2.133M
YoY Change -46.08% 7.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20475143
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23247456
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22748432
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17813081
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22748432
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17813081
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001718939
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P0Y
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P0Y
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P0Y
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-41252
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
T Stamp Inc
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3017 Bolling Way NE, Floors 1 and 2
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30305
CY2022Q1 dei City Area Code
CityAreaCode
404
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
806-9906
CY2022Q1 dei Security12b Title
Security12bTitle
Class A Common Stock, $0.01 par value per share
CY2022Q1 dei Trading Symbol
TradingSymbol
IDAI
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Goodwill
Goodwill
1248664
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23561485
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5836151
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3475695
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1033359
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1278286
CY2022Q1 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
254
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
13648
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1221541
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
996602
CY2022Q1 us-gaap Assets Current
AssetsCurrent
8091305
CY2021Q4 us-gaap Assets Current
AssetsCurrent
5764231
CY2022Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1246755
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1160044
CY2022Q1 us-gaap Goodwill
Goodwill
1248664
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
204630
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
201807
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
111585
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
111768
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
150601
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
178140
CY2022Q1 us-gaap Assets
Assets
11053540
CY2021Q4 us-gaap Assets
Assets
8664654
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
653780
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
304140
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
171221
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
252773
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1318435
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1059532
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
321490
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
503433
CY2021Q4 idai Contract With Customer Deposits Current
ContractWithCustomerDepositsCurrent
280108
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2464926
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2399986
CY2022Q1 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
334106
CY2021Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
374694
CY2022Q1 us-gaap Interest Payable Current
InterestPayableCurrent
16045
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
12252
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
838136
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
856258
CY2022Q1 us-gaap Liabilities
Liabilities
3637168
CY2021Q4 us-gaap Liabilities
Liabilities
3630938
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Minority Interest
MinorityInterest
161439
CY2022Q1 us-gaap Minority Interest
MinorityInterest
161439
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
37500000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
37500000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23247456
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20475143
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
232475
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
204751
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
282565
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
282565
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
35778493
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
31822079
CY2022Q1 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
102337
CY2021Q4 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
130267
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
246550
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
183900
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28900248
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27208186
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7416372
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5033716
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11053540
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8664654
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2821044
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
532283
CY2022Q1 idai Cost Of Goods And Services Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServicesExcludingDepreciationDepletionAndAmortization
693978
CY2021Q1 idai Cost Of Goods And Services Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServicesExcludingDepreciationDepletionAndAmortization
257419
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
493686
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
755036
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3120572
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1334041
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
153928
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
121453
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
4462164
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
2467949
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1641120
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1935666
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3958
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-32220
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-40588
CY2022Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
6941
CY2022Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
94513
CY2021Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
64007
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-50942
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-96227
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1692062
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2031893
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1692062
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-2031893
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1692062
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2031893
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22748432
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17813081
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1692062
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-2031893
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
62650
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
44622
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
62650
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
44622
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1629412
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1987271
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1629412
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1987271
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2073659
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2406492
CY2021Q1 idai Stockholder S Equity Repayment Of Shareholders Loan Through In Kind Services
StockholderSEquityRepaymentOfShareholdersLoanThroughInKindServices
27930
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
44622
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2031893
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2692921
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5033716
CY2022Q1 idai Exercise Of Warrants To Common Stock
ExerciseOfWarrantsToCommonStock
3383762
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
53314
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
203438
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
55838
CY2022Q1 idai Stockholder S Equity Repayment Of Shareholders Loan Through In Kind Services
StockholderSEquityRepaymentOfShareholdersLoanThroughInKindServices
27930
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
287786
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
62650
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1692062
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7416372
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1692062
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2031893
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
153928
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
121453
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
287786
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
172111
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-40588
CY2022Q1 idai Repayment Of Shareholders Loan Through In Kind Services
RepaymentOfShareholdersLoanThroughInKindServices
27930
CY2021Q1 idai Repayment Of Shareholders Loan Through In Kind Services
RepaymentOfShareholdersLoanThroughInKindServices
27930
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-244927
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
325466
CY2022Q1 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-13394
CY2021Q1 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-5820
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
224939
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-139913
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-27539
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
604378
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-58033
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-181943
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-77692
CY2021Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
97558
CY2022Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-81552
CY2021Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-106513
CY2022Q1 idai Increase Decrease In Customer Deposits Liability
IncreaseDecreaseInCustomerDepositsLiability
-280108
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1141310
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2132370
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10059
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
497
CY2022Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
206523
CY2021Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
90621
CY2022Q1 idai Payments For Patent Application Costs
PaymentsForPatentApplicationCosts
28173
CY2021Q1 idai Payments For Patent Application Costs
PaymentsForPatentApplicationCosts
45245
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-244755
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-233921
CY2022Q1 idai Proceeds From Exercise Of Warrants To Common Stock
ProceedsFromExerciseOfWarrantsToCommonStock
3383762
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
53314
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
203438
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2406492
CY2022Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
55838
CY2021Q1 idai Proceeds From Loan From Maltese Government
ProceedsFromLoanFromMalteseGovernment
540607
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3696352
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2947099
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
50169
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
46395
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2360456
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
627203
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3475695
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1469952
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5836151
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2097155
CY2021Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
5
CY2021Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
24000
CY2021Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
61582
CY2021Q3 idai Amount Of Authorized Units
AmountOfAuthorizedUnits
5000000.00
CY2021Q3 idai Number Of Warrants Per Unit
NumberOfWarrantsPerUnit
1
CY2021Q3 idai Minimum Target Amount Under Offering
MinimumTargetAmountUnderOffering
100000
CY2022Q1 idai Units Issued During Period Value Additional New Issues
UnitsIssuedDuringPeriodValueAdditionalNewIssues
49605
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1690000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1140000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28900000
CY2022Q1 idai Cessation Period For Implementing Ice Obligations
CessationPeriodForImplementingIceObligations
P90D
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span><i style="font-style:italic;"> </i><span style="font-style:italic;font-weight:bold;">—</span><i style="font-style:italic;"> </i>The preparation of the consolidated financial statements in conformity with United States generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, we evaluate our estimates that include, but are not limited to, percentage of completion related to revenue contracts that are not fully complete at the end of a fiscal year, capitalization and estimated useful life of internal-use software, the allowance for doubtful accounts, the fair value of financial assets and liabilities, the useful lives of property and equipment and intangible assets, the recoverability of goodwill, stock-based compensation including the determination of the fair value of our common stock, impairment of long-lived assets, the valuation of deferred tax assets and uncertain tax positions, and warrant liabilities. We base our estimates on assumptions, both historical and forward-looking trends, and various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</p>
CY2022Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Major Customers and Concentration of Risks </span><span style="font-style:italic;font-weight:bold;">—</span> Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, and accounts receivable. We maintain our cash and cash equivalents with high-quality financial institutions mainly in the United States; the composition of which are regularly monitored by us. The Federal Deposit Insurance Corporation covers $250,000 for substantially all depository accounts. The Company from time to time may have amounts on deposit in excess of the insured limits. As of March 31, 2022 and December 31, 2021, the Company had $4.18 million and $2.25 million in U.S. bank accounts, respectively, which exceeded these insured amounts. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;background:#ffffff;margin:0pt;">For accounts receivable, we are exposed to credit risk in the event of nonpayment by customers to the extent the amounts are recorded in the consolidated balance sheets. We extend different levels of credit and maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of credit worthiness and applying other credit risk monitoring procedures.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;background:#ffffff;margin:0pt;">One customer represented 63% and 51% of the balance of total accounts receivable as of March 31, 2022 and December 31, 2021, respectively. Two other customers represented 34% and 41% of total accounts receivable as of March 31, 2022 and December 31, 2021, respectively. The Company seeks to mitigate its credit risk with respect to accounts receivable by contracting with large commercial customers and government agencies and regularly monitoring the aging of accounts receivable balances. As of March 31, 2022 and December 31, 2021, the Company had not experienced any significant losses on its accounts receivable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;background:#ffffff;margin:0pt;">During the three months ended March 31, 2022, the Company sold to primarily four customers which made up approximately 98% of total net revenue. The remaining revenue recognized during the three months ended March 31, 2022, which made up approximately 2% of total net revenue, was from various other customers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;background:#ffffff;margin:0pt;">During the three months ended March 31, 2021, the Company sold to primarily three customers which made up approximately 96% of total net revenue. The remaining revenue recognized during the three months ended March 31, 2021, which made up approximately 4% of total net revenue, was from various other customers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt 0pt 12pt 0pt;">The loss of, or substantial reduction, in statements of work from the Company’s major customers could have a material effect on the consolidated financial statements.</p>
CY2022Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
58000
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q1 idai Maximum Number Of Warrants Issued To Purchase Common Stock In Future
MaximumNumberOfWarrantsIssuedToPurchaseCommonStockInFuture
1000000.00
CY2022Q1 idai Percentage Of Discount Of Future Issuance Of Preferred Stock
PercentageOfDiscountOfFutureIssuanceOfPreferredStock
0.20
CY2016Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
250000
CY2022Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
250000
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2016Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
50000
CY2020Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
32092
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
125000
CY2022Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
5376663
CY2021Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
7752009
CY2021Q4 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
67000
CY2020Q1 idai Warrants Strike Price
WarrantsStrikePrice
1.60
CY2022Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1435068
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.00
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
483316
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
319996
CY2022Q1 us-gaap Prepaid Rent
PrepaidRent
95809
CY2021Q4 us-gaap Prepaid Rent
PrepaidRent
100425
CY2022Q1 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
70445
CY2021Q4 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
68798
CY2022Q1 idai Prepaid Sponsorship Current
PrepaidSponsorshipCurrent
75000
CY2021Q4 idai Prepaid Sponsorship Current
PrepaidSponsorshipCurrent
100000
CY2022Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
90501
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
75106
CY2022Q1 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
406470
CY2021Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
332277
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1221541
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
996602
CY2022Q1 idai Capitalized Computer Software Useful Life
CapitalizedComputerSoftwareUsefulLife
P5Y
CY2022Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2744918
CY2021Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2538395
CY2022Q1 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
1498163
CY2021Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
1378351
CY2022Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1246755
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1160044
CY2022Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
120000
CY2021Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
106000
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
162946
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
154009
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
51361
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
42241
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
111585
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
111768
CY2022Q1 us-gaap Depreciation
Depreciation
10000
CY2021Q1 us-gaap Depreciation
Depreciation
11000
CY2022Q1 us-gaap Income Tax Receivable
IncomeTaxReceivable
150601
CY2021Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
178140
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
150601
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
178140
CY2022Q1 idai Compensation Payable
CompensationPayable
523801
CY2021Q4 idai Compensation Payable
CompensationPayable
597849
CY2022Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
362505
CY2022Q1 idai Accrued Employee Taxes
AccruedEmployeeTaxes
268024
CY2021Q4 idai Accrued Employee Taxes
AccruedEmployeeTaxes
349256
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
164105
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
112427
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1318435
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1059532
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
320544
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
294629
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-115914
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-92822
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
204630
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
201807
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
74082
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
97068
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
32568
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
912
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
204630
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2821044
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
532283
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1692062
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2031893
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22748432
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17813081
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2022Q1 us-gaap Dilutive Securities
DilutiveSecurities
8998832
CY2021Q1 us-gaap Dilutive Securities
DilutiveSecurities
9173097
CY2020Q4 idai Loans Receivable With Abated Interest Rate
LoansReceivableWithAbatedInterestRate
0.0025
CY2020Q4 idai Loans Receivable Kind In Services Per Month
LoansReceivableKindInServicesPerMonth
9000
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P36M
CY2017Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
75000
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
37000
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.34
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.11
CY2022Q1 idai Share Based Compensation Arrangement Weighted Average Grant Date Fair Value Of Options Granted Amount
ShareBasedCompensationArrangementWeightedAverageGrantDateFairValueOfOptionsGrantedAmount
29000
CY2021Q1 idai Share Based Compensation Arrangement Weighted Average Grant Date Fair Value Of Options Granted Amount
ShareBasedCompensationArrangementWeightedAverageGrantDateFairValueOfOptionsGrantedAmount
81000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
287786
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
172111
CY2022Q1 idai Related Party Transactions Expenses Incurred In Relation To Legal Services
RelatedPartyTransactionsExpensesIncurredInRelationToLegalServices
21000
CY2021Q1 idai Related Party Transactions Expenses Incurred In Relation To Legal Services
RelatedPartyTransactionsExpensesIncurredInRelationToLegalServices
0
CY2022Q1 idai Related Party Transaction Amounts Payable
RelatedPartyTransactionAmountsPayable
0
CY2021Q4 idai Related Party Transaction Amounts Payable
RelatedPartyTransactionAmountsPayable
0
CY2020Q4 idai Loan Receivable Term
LoanReceivableTerm
P3Y
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
335000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1408240
CY2020Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.20
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P24M
CY2017Q3 idai Loans Issued
LoansIssued
176282
CY2022Q1 idai Total Shareholder Loan Balances
TotalShareholderLoanBalances
0
CY2021Q4 idai Total Shareholder Loan Balances
TotalShareholderLoanBalances
225000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
216540000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
103484000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
82041000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
55847000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2819000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
460731000
CY2021Q1 idai Rental Expense
RentalExpense
145000
CY2022Q1 idai Rental Expense
RentalExpense
145000

Files In Submission

Name View Source Status
0001410578-22-001381-index-headers.html Edgar Link pending
0001410578-22-001381-index.html Edgar Link pending
0001410578-22-001381.txt Edgar Link pending
0001410578-22-001381-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
idai-20220331.xsd Edgar Link pending
idai-20220331x10q.htm Edgar Link pending
idai-20220331x10q_htm.xml Edgar Link completed
idai-20220331xex31d1.htm Edgar Link pending
idai-20220331xex31d2.htm Edgar Link pending
idai-20220331xex32d1.htm Edgar Link pending
idai-20220331_cal.xml Edgar Link unprocessable
idai-20220331_def.xml Edgar Link unprocessable
idai-20220331_lab.xml Edgar Link unprocessable
idai-20220331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending